ArticleArchives of dermatological research2025
Osteopontin promotes keratinocyte proliferation by G0/G1 cell cycle arrest in psoriasis.
Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Psoriasis is a chronic inflammatory dermatological disorder that is featured by the abnormal activation of epidermal keratinocytes. Osteopontin (OPN) is a multifunctional phosphoprotein upregulated in psoriasis. OPN levels in the skin of psoriasis patients and healthy subjects were assessed by immunohistochemistry. To evaluate the potential role of OPN in keratinocyte proliferation, the knockdown model of OPN was constructed using OPN siRNA. The proliferative activity of HaCaT cells was assessed via the CCK-8 and EdU cell proliferation assays. The cell cycle and apoptosis were analyzed using flow cytometry. Western blot assay was conducted in order to investigate the expression levels of cyclins, CDKs, and apoptosis-associated proteins. OPN expression was increased in the epidermis of psoriasis lesions and OPN knockdown inhibited the proliferation of keratinocytes. OPN affected keratinocyte proliferation by G0/G1 cell cycle arrest and promoted their apoptosis, which involved the regulation of cyclins (Cyclin D1 and Cyclin A2), cyclin-dependent kinases (CDK2 and CDK4), and apoptosis proteins (Bim, Bcl-2, and Caspase-3) in keratinocytes. OPN expression was significantly higher in keratinocytes of psoriasis lesions. OPN knockdown inhibited the keratinocyte proliferation, arrested the G0/G1 cell cycle, and promoted apoptosis. This suggests that OPN may provide a new mechanism for the proliferation of keratinocytes in psoriasis.
Indexed as
Identifiers
40035859What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.